Dignan's sale was executed under a Rule 10b5-1 trading plan adopted nearly a year prior, indicating routine portfolio management rather than a sudden shift in confidence.
Kraft Heinz (NASDAQ:KHC) Chief Executive Officer Steve Cahillane said the company is seeing early evidence that its increased brand investment is improving consumption and market-share trends, though he emphasized that performance has not yet reached acceptable levels.
Speaking at a fireside chat,
Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman told attendees at the Cantor Healthcare Conference that the company’s near-term focus is the commercial launch of TONMYA, its FDA-approved treatment for fibromyalgia in adults, while it advances development programs in Lyme disease prevention and
XPH delivered 57% returns over one year but swung 31% lower at its worst. IXJ offers steadier performance with higher income and $4.2 billion in assets for easier trading.
Nowgoal mobi vươn lên thành nền tảng cung cấp dữ liệu tỷ số bóng đá trực tuyến uy tín và phổ biến rộng rãi tại Việt Nam. Chúng tôi mang đến hệ thống thông
Apple (NASDAQ:AAPL) has a small dividend, but it's growing steadily. After a strong device showcase, perhaps the best spot for the shares is your TFSA.
Editas Medicine (NASDAQ:EDIT) outlined its strategy as an in vivo gene-editing company and said it remains on track to dose patients this year in a clinical study of its lead program, EDIT-401, for lowering LDL cholesterol.
Speaking at the Cantor Healthcare Conference, President and Chief Executive
